Quality Choice Earwax Removal Products Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bell Pharmaceuticals, Inc. is recalling 15,843 units of Quality Choice earwax removal products due to subpotent carbamide peroxide.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Bell Pharmaceuticals, Inc. initiated a voluntary recall of Quality Choice earwax removal products because the drug is subpotent, with low pH and significantly reduced assay (~0.6% vs expected ~6.7%).
Which Products Are Affected
The recall covers QC Quality Choice, Carbamide Peroxide, 6.5%, 0.5 FL. OZ. (15 mL) including a) Washer Bulb included (NDC 63868-026-15) and b) 1 bottle (NDC 63868-027-16). Affected lots are a) 1505121, 1505342, exp 2027-04 and b) 1505381, exp 2027-04. A total of 15,843 units were distributed nationwide in the United States. The recall number is D-0680-2026.
What You Should Do
Consumers should refer to the FDA recall notice for guidance on affected products.
Why This Matters
The recall involves an ongoing Class II drug product distributed across the U.S. due to reduced potency.
Source
FDA recall D-0680-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (874 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.